Hydroxychromones and B-ring-substituted 5,6,7-trihydroxyflavones were prepared to evaluate the contribution of the B ring of baicalein (5,6,7-trihydroxyflavone, 1) to its potent -glucosidase inhibitory activity. Hydroxychromones, which lack 6-hydroxyl substitution, did not show any inhibitory activity, while 5,6,7-trihydroxy-2-methylchromone (5) showed high activity. Among the tested B-ring-substituted 5,6,7-trihydroxyflavones, the 4 0 -hydroxy-, 3 0 ,4 0 -dihydroxy-, and 3 0 ,4 0 ,5 0 -trihydroxy-substituted derivatives were found to give more activity than that of 1. The methoxy-substituted derivatives, however, showed less activity than 1. The results suggest that the B ring of 1 was not essential, although advantageous to the activity; hydroxyl substitution on the B ring of 5,6,7-trihydroxyflavones was favorable to the activity, whereas methoxyl substitution was unfavorable; at least 4 0 -hydroxyl substitution of 5,6,7-trihydroxyflavones was required for enhanced activity, in which the number of hydroxyl groups did not take part.
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The -glucosidase enzyme catalyzes the final step in the digestive process of carbohydrates; hence, -glucosidase inhibitors can retard the decomposition and absorption of dietary carbohydrates to suppress postprandial hyperglycemia.
1) The results of the previous study on 6-hydroxylated flavonoids as -glucosidase inhibitors indicate that the 5,6,7-trihydroxyflavone structure was crucial for exerting high activity. 2, 3) We have recently reported the effect of A-ring substitution of baicalein (1), 5,6,7-trihydroxyflavone, on theglucosidase inhibition. 4) Structure-activity relationship (SAR) studies validated the importance of the 6-hydroxyl group of 1 to this activity. The 8-substituted derivatives of 1 tended to have less activity regardless of the electronic nature of the substituents, suggesting that excess steric bulkiness around position 8 was detrimental to the potent inhibitory activity.
We examined in this study a class of hydroxychromones and B-ring-substituted 5,6,7-trihydroxyflavones in order to evaluate the contribution of the B-ring of 1 toward the -glucosidase inhibitory activity.
Materials and Methods
General experimental procedures. NMR spectra were recorded with a Bruker AMX500 instrument ( 1 H, 500 MHz;
13 C, 125 MHz). Chemical shift data were calculated from the residual solvent signals of H 3.30 and C 49.0 ppm in methanol-d 4 , H 2.04 and C 29.8 ppm in acetone-d 6 , H 7.24 and C 77.0 ppm in chloroform-d, and H 2.49 and C 39.5 ppm in dimethyl sulfoxide-d 6 . Field desorption (FD), FD-high resolution (HR), electron ionization (EI), and EI-HR mass spectra (MS) were obtained with a Jeol JMS-SX102A instrument. Melting point data were measured with a hot-stage apparatus and are uncorrected. The following experimental conditions were used for chromatography: ordinary-phase silica gel column chromatography, Wakogel C-300 (Wako Pure Chem. Co., Osaka, Japan); reverse-phase ODS column chromatography, Cosmosil 75C 18 -OPN (Nacalai Tesque, Kyoto, Japan); TLC, precoated TLC plates with silica gel 60 F 254 (Merck, 0.25 mm or 0.5 mm thickness, normal phase) and RP-18 F 254s (Merck, 0.2 mm thickness, reverse phase). Spots were detected by a UV lamp (254 nm). Preparative HPLC was conducted with an Inertsil PREP-ODS column (20:0 Â 250 mm, GL-Science). Detailed analytical conditions are mentioned in each section.
All chemicals used were of reagent grade and were purchased from Wako Pure Chem. Co. (Osaka, Japan) unless otherwise stated. Biflorin (2) was isolated from dried flower buds of clove in our laboratory. 5) Rat intestinal acetone powder, 2,3,4-trihydroxybenzaldehyde (6) and 2 0 ,3 0 ,4 0 -trihydroxyacetophenone (7), were supplied by Sigma Aldrich Japan Co. (Tokyo, Japan). Acetone and tetrahydrofuran were dried by storing over 3A molecular sieves. All solvents were distilled before use.
y To whom correspondence should be addressed. Fax: +81-11-706-2496; E-mail: junk@chem.agr.hokudai.ac.jp Assay for rat intestinal -glucosidase inhibitory activity. The -glucosidase inhibitory activity was measured as described previously.
4) The concentration of an inhibitor required to inhibit 50% of theglucosidase activity under the assay conditions is defined as the IC 50 value. The activity of each test compound is presented as the relative value (RA) defined as IC 50 (baicalein) /IC 50 (test compound) . 6) 5,7-Dihydroxy-2-methylchromone (3). A mixture of biflorin (2, 52 mg, 0.15 mmol), phenol (0.22 g, 2.34 mmol) and hydriodic acid (1.7 g/ml specific gravity, 1 ml) was refluxed for 6 hr. The reaction mixture was cooled, and an aqueous solution of NaHSO 3 (10%, 5 ml) was added to it. The precipitate appearing was collected by filtration and washed with water. The solid was dissolved in a small amount of methanol and subjected to normal-phase silica gel column chromatography, using chloroform-methanol 5,6,7-Trihydroxy-2-methylchromone (5). To an icecooled solution of 4 (117 mg, 0.5 mmol) in 4% NaOH (4 ml, 4 mmol), was added dropwise a mixture of 30% hydrogen peroxide (200 l, 1.5 mmol) and 4% NaOH (2 ml, 2 mmol) in an atmosphere of argon over 3 hr. After acidifying with 1 M HCl, the solid formed was extracted with ethyl acetate (3 Â 50 ml). The ethyl acetate layer was washed with water and dried over sodium sulfate. After removing the solvent, the residue was dissolved in a small amount of methanol and subjected to reverse-phase column chromatography, using water-methanol-formic acid (60:40:0.1) as the eluent, to give crude 5. This was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (45:65:0.1); flow rate, 4.0 ml/min; detection, UV 254 nm) to give 5 (t R 13 min, 12 mg, 12%) as yellow powder: mp 286-287 C (lit. 8) 6-Acetyl-5,7-dihydroxy-3 0 ,4 0 ,5 0 -trimethoxyflavone (8b). Zinc chloride (a 1.0 M solution in diethyl ether, 0.5 ml, 0.5 mmol) was mixed with glacial acetic acid (2 ml), and the diethyl ether was then removed. After adding acetic anhydride (60 l, 0.64 mmol) and 8a (0.22 g, 0.64 mmol), the temperature was maintained at 140-150 C for 2 hr while frequently stirring. The reaction mixture was cooled to room temperature and poured into icecooled water. The solid material was separated and purified by silica gel preparative thin-layer chromatography, using chloroform-methanol (10: 
5,6,7-Trihydroxy-3
0 ,4 0 ,5 0 -trimethoxyflavone (8) . To a stirred mixture of boric acid (66 mg, 1.1 mmol) and 30% hydrogen peroxide (54 l, 0.47 mmol) in dry THF (5 ml) was added conc. H 2 SO 4 (22 l), and the reaction mixture was further stirred at room temperature for 30 min. A solution of 8b (82 mg, 0.21 mmol) in dry THF (5 ml) was added, and the reaction mixture was stirred at 60 C for 36 hr. After cooling to room temperature, the reaction mixture was extracted with ethyl acetate (3 Â 25 ml). The extract was washed with water and concentrated to dryness. The residue was dissolved in a small amount of methanol and subjected to reversephase column chromatography, using water-methanolformic acid (40:60:0.1) as the eluent, to give crude 8. This was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (30:70:0.1); flow rate, 5.0 ml/min; detection, UV 254 nm) to give 8 (9) . A mixture of 8 (75.6 mg, 0.21 mmol), 47% aqueous hydrobromic acid (1.4 ml, 12.6 mmol) and acetic acid (11.2 ml) was heated under reflux for 23 hr. After cooling to room temperature, the reaction mixture was extracted with 1-butanol (2 Â 50 ml). The organic phase was washed with water and concentrated to dryness. The residue was dissolved in a small amount of methanol and subjected to reversephase column chromatography, using water-methanolformic acid (50:50:0.1) as the eluent, to yield crude 9. This was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (50:50:0.1); flow rate, 5.0 ml/min; detection, UV 254 nm) to give 9 (t R 18 min, 52 mg, 82%) as pale yellow powder: mp > 300 
0 -H), 10.82 (1H,s,7-OH), 12.92(1H,s, 5-OH).
0 ,4 0 -dimethoxyflavone (10) . By the same method as that used for 8b, 10a (1.9 g, 6 mmol) was acetylated to 6-acetyl-5,7-dihydroxy-3 0 ,4 0 -dimethoxyflavone, this in turn being oxidized to 10 by the same method as that used for 5. Crude 10 was purified by preparative HPLC (mobile phase, water-methanolformic acid (30:70:0.1); flow rate, 4.5 ml/min; detection, UV 254 nm) to give 10 (t R 6-Hydroxyluteolin (11). Compound 10 (105 mg, 0.32 mmol) was treated with 47% aqueous hydrobromic acid (1.08 ml, 9.6 mmol) and acetic acid (9 ml) as described for the formation of 9 from 8. The resulting solid was subjected to reverse-phase column chromatography, using water-methanol-formic acid (50:50:0. 6-Hydroxyapigenin (13). Compound 12 (125 mg, 0.42 mmol) was treated with 47% aqueous hydrobromic acid (4.2 ml, 4.2 mmol) and acetic acid (4 ml) as described for the formation of 9 from 8. After separating by reverse-phase column chromatography, using watermethanol-formic acid (50:50:0.1) as the eluent, the crude material was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (40:60:0.1); flow rate, 4.5 ml/min; detection, UV 254 nm) to give 13 
5,6,7-Trihydroxy-2
0 -methoxyflavone (14) . By the same method as that used for 10, 14a (1.7 g, 6 mmol) was converted to 14. After separating by reverse-phase column chromatography, using water-methanol-formic acid (60:40:0.1) as the eluent, the crude material was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (35:65:0.1); flow rate, 5 ml/min; detection, UV 254 nm) to give 14 (t R 28 min, 76 mg, 25%) as yellow powder: mp 291-293 C; EI-HR-MS m=z 300.0625 (calcd. for C 16 (15) . Compound 14 (120 mg, 0.4 mmol) was treated with 47% aqueous hydrobromic acid (4 ml) and acetic acid (4 ml) as described for the formation of 9 from 8. After separating by reverse-phase column chromatography, using watermethanol-formic acid (50:50:0.1) as the eluent, the crude material was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (40:60:0. 
5,7-Dihydroxy-3
0 -methoxyflavone (16a). 3-Methoxybenzoyl chloride (4.08 g, 24 mmol) was reacted with 2 0 ,4 0 ,6 0 -trihydroxyacetophenone (3.36 g, 20 mmol) in a similar way to that described for 8a to give 12a (2.23 g, 40%) as yellow powder: mp 232-235 C (lit. 10) 234 C); HR-FD-MS m=z 284.0680 (calcd. for C 16 H 12 O 5 , 284.0685).
5,6,7-Trihydroxy-3
0 -methoxyflavone (16) . By the same method as that used for 10, 16a (1.1 g, 4 mmol) was converted to 16. After separating by reverse-phase column chromatography, using water-methanol-formic acid (60:40:0.1) as the eluent, the crude material was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (30:70:0.1); flow rate, 5 ml/min; detection, UV 254 nm) to give 16 (t R 24 min, 65 mg, 21%) as yellow powder: mp 265 C; FD- (17) . Compound 16 (135 mg, 0.45 mmol) was treated with 47% aqueous hydrobromic acid (6 ml) and acetic acid (6 ml) as described for the formation of 9 from 8. After separating by reversephase column chromatography, using water-methanolformic acid (50:50:0.1) as the eluent, the crude material was further purified by preparative HPLC (mobile phase, water-methanol-formic acid (30:70:0.1); flow rate, 4 ml/min; detection, UV 254 nm) to give 17 (t R 18 min, 91 mg, 81%) as yellow powder: mp > 300 0 -H).
6-Acetyl-5,7-dihydroxy-4 0 -nitroflavone (18a). By the same method as that described for 4, 18a was obtained from 4-nitrobenzoylacetic acid ethyl ester (5 g, 27 mmol) and 2 0 ,4 0 ,6 0 -trihydroxyacetophenone (11 g, 46 mmol) in boiling diphenyl ether (25 ml). Recrystallization from chloroform and hexane gave 18a 5,6,7-Trihydroxy-4 0 -nitroflavone (18). Compound 18a (5 mmol, 1.71 g) was dissolved in 12 ml of 4% NaOH and 12 ml of pyridine. The mixture was cooled in an ice bath, and hydrogen peroxide (20%, 12 ml) was added dropwise while stirring during 5 min. The reaction mixture was kept stirred for 1 hr under argon gas. Acidification with 2 M HCl resulted in the separation of 18 as a yellow precipitate. Recrystallization from ethyl acetate and hexane gave 18 (0.96 g, 61%) as yellow powder: mp > 300 C; FD-HR-MS m=z 315.0359 (calcd. for C 15 H 9 O 7 N, 315.0379);
1 H-NMR (DMSO- 
Results and Discussion
Biflorin (2) was deglucosylated with hydriodic acid to give 3.
7) Treatment of 2 0 ,4 0 ,6 0 -trihydroxyacetophenone with ethyl acetoacetate in boiling diphenyl ether led to 4, whose acetyl group was oxidized by Dakin hydrogen peroxide oxidation to afford 5.
8) 3 0 ,4 0 ,5,5 0 ,6,7-Hexahydroxyflavone (9) was obtained via a four-step synthesis starting with the condensation of 2 0 ,4 0 ,6 0 -trihydroxyacetophenone and 3,4,5-trimethoxybenzoyl chloride to give the corresponding flavone 8a in moderate yield. 11) In the next step, 8a was acetylated to give 8b, which in turn was oxidized with a hydrogen/boric acid system to yield 8. 8, 12) In the final step, the methoxyl groups of 8 were hydrolyzed by hydrobromic acid in glacial acetic acid to give 9 in a high yield. 13) Compounds 10-17 were obtained according to the procedures used for the preparation of 8 and 9, except that the acetyl group was oxidized by Dakin hydrogen peroxide oxidation.
Compounds 18 and 20 were obtained by oxidizing the acyl group, using hydrogen peroxide/4% NaOH-pyridine from compounds 18a and 20a, respectively, which had been prepared by the method described for 4.
14)
Hydrogenation of 18 in the presence of 10% Pd-C afforded 19. 15) In order to evaluate the importance of the B-ring of 1 on the inhibitory activity against -glucosidase, B-ringeliminated hydroxychromones (2) (3) (4) (5) , as well as B-and C-ring-eliminated 2,3,4-trihydroxybenzaldehyde (6) and 2 0 ,3 0 ,4 0 -trihydroxyacetophenone (7) were tested for their inhibition against rat intestinal -glucosidase with sucrose as the substrate (Table 1) . Hydroxychromones 2-4, which lacked 6-hydroxyl substitution, did not show any inhibitory activity, while 5,6,7-trihydroxychromone 5 showed high activity, although the activity of 5 was a little weaker than that of 1. This result suggested that the B-ring of 1 was not essential, although advantageous to the activity. Further evidence supporting this rationale is the surprising fact that 6 and 7, having neither a B-nor C-ring, still retained the activity, even though their activity was considerably weaker than that of 1 or 5. In consequence, it is suggested that 5,6,7-trihydroxyl substituents and presumably a 4-carbonyl group were important as a minimal structure for exerting the inhibitory activity and that the C-ring in chromones and B-ring in flavones effectively enhanced this activity.
It was indicated in the previous paper that 6-hydroxyluteolin (11, IC 50 ¼ 10 M) and 6-hydroxyapigenin (13, IC 50 ¼ 12 M), both of which have an additional hydroxyl group on the B-ring, showed higher activity than that of 1 (IC 50 ¼ 32 M).
3) In order to clarify the contribution of the position and number of hydroxyl groups on the B-ring of 1 to the inhibitory activity, we examined the inhibitory activity of a series of B-ring-hydroxylated 5,6,7-trihydroxyflavones (9, 11, 13, 15 and 17) together with the corresponding methoxyl counterparts (8, 10, 12, 14 and 16) , as well as the nitro (18), amino (19) and fluoro (20) derivatives ( Table 2) . As shown in Table 2 , all of the tested 5,6,7-trihydroxyflavones (8-17, 19 and 20) were more or less active, except for 18 (IC 50 > 1 mM), which validates the importance of the basic structure of 5,6,7-trihydroxyflavone for the activity.
Among the B-ring-hydroxylated 5,6,7-trihydroxyflavones, 9 (RA ¼ 1:495), 11 (RA ¼ 1:791), and 13 (RA ¼ 1:375), all of which carried the 4 0 -OH group, were more active than 1 (RA ¼ 1), although the inhibitory activity was independent upon the number of hydroxyl groups on the B-ring. The highest activity was observed for dihydroxylated 11, compared to monohydroxylated 9 and trihydroxylated 13. On the other hand, the compounds with a hydroxyl group at the 2 0 -(15, RA ¼ 0:733) or 3 0 -(17, RA ¼ 0:770) position all showed lower activity than that of 1. These results indicate that only 4 0 -hydroxylation of the B-ring enhanced the inhibitory activity of 1, although extra hydroxyl groups were not always advantageous, and that 2 0 -or 3 0 -hydroxylation was detrimental to the activity. A comparison of the B-ring-methoxylated 5,6,7-trihydroxyflavones (8, 10, 12, 14 and 16) with the corresponding B-ring-hydroxylated compounds (9, 11, 13, 15 and 17) revealed that methylation of the hydroxyl groups on the B-ring obviously reduced the activity (8 > 9, 10 > 11, 12 > 13, 14 > 15, and 16 > 17). Hence, the methoxyl group substitution on the B-ring of 1 was unfavorable for the activity, unlike the hydroxyl group substitution.
The fact that the -glucosidase inhibitory activity of 1 was enhanced by hydroxyl substitution on the B-ring (except for 15 and 17) and reduced by methoxyl substitution leads us to believe that the influence of the substituents was not due to their electronic properties, since both the hydroxyl and methoxyl groups were electron-releasing and had negative Hammett constants. 16) In addition, the result that the introduction of both strong electron-donating (19) and electron-withdrawing (18 and 20) groups at the 4 0 -position of 1 did not lead to any increase of the activity compared to 1 supports this rationale. Steric hindrance did not account for the unfavorable effect of methoxyl group substitution on the B-ring of 1 on the activity, since 20, which carried a less bulky substituent at the 4 0 -position of 1, showed weaker inhibition than 12, 13 or 19 did. The question still remains, however, of why the 4 0 -OH substitution found in 9, 11 and 13 enhanced the activity compared to that of 1. After eliminating the electronic and steric effects of the substituents on the B-ring, the acidic hydroxyl group at the 4 0 -position might have interacted directly with a specific part of the enzyme by constructing an H-bond. The enhanced affinity to the enzyme could improve the inhibitory potency. On the other hand, the methoxyl group substituted on the B-ring (e.g., as found in 8, 10 or 12) would simply have caused repulsion with the enzyme so as to reduce the inhibitory activity. In summary, this study has disclosed considerable information about the structure-activity relationship in respect of the number and relative position of the hydroxyl groups on the B-ring of 1 for enhancing the inhibitory activity against rat intestinal -glucosidase. The combined results of our present and previous 4) studies would lead to the future design of more potentglucosidase inhibitors with a rational molecular structure, although the detailed three-dimensional structure of the rat enzyme remains obscured. It is well known that polyphenols efficiently interact with proteins and lead to inhibited enzyme activities. 17) However, our preliminary results show that baicalein specifically inhibited rat intestinal sucrase but had little effect on the activities of other glycosidases including -amylase, -glucosidase, -mannosidase and -galactosidase. Details of the enzyme specificity of the inhibitory activity of baicalein and its related compounds will be discussed elsewhere.
